2008
DOI: 10.1208/s12249-008-9035-y
|View full text |Cite
|
Sign up to set email alerts
|

Comparative In Vitro Study of Six Carbamazepine Products

Abstract: Abstract. The purpose of present study was to evaluate commercial preparations of carbamazepine tablets with respect to drug release through a defined sequence of experiments using Minitab software. The compliance of products with respect to United States Pharmacopeia (USP) dissolution test and comparison of the products with respect to drug release in different dissolution conditions is reported in the present paper. The different dissolution conditions studied include dissolution medium (1% SLS in purified w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…There are many researches that emphasize the need to evaluate different brands of the same generic drug in order to screen the quality product available in local market 7,[31][32][33] .…”
Section: Discussionmentioning
confidence: 99%
“…There are many researches that emphasize the need to evaluate different brands of the same generic drug in order to screen the quality product available in local market 7,[31][32][33] .…”
Section: Discussionmentioning
confidence: 99%
“…The dissolution media and method used in this study were selected based on previous reports, indicating its biopredictive ability and previously developed IVIVC. Taking into account the reported values for CBZ solubility (2.96 mg/mL in deionized water containing 1% of SLS [29] and 3.412 ± 0.13 mg/mL in the same media [30]) 900 mL of media does not provide sink conditions for a 400 mg tablet. The maintenance of sink conditions is, in general, required in quality control media, but for IVIVC, non-sink conditions can be of application.…”
Section: Modeling Dissolution Datamentioning
confidence: 99%
“…According to the screening matrix, nine formulations were prepared with combination of each disintegrant with volatile materials containing 40% carbamazepine in each 250 mg tablet. To study the extent of influence of each volatile material and disintegrant on disintegration time and tablet friability, plots of main effects were generated using a commercially available statistical software (Minitab V R statistical software; version 17, Minitab Inc., State College, PA) 28 .…”
Section: Screening and Establishment Of Cmasmentioning
confidence: 99%